Does CLOBETASOL Cause Therapy cessation? 9 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Therapy cessation have been filed in association with CLOBETASOL (CLOBETASOL PROPIONATE). This represents 0.1% of all adverse event reports for CLOBETASOL.
9
Reports of Therapy cessation with CLOBETASOL
0.1%
of all CLOBETASOL reports
0
Deaths
2
Hospitalizations
How Dangerous Is Therapy cessation From CLOBETASOL?
Of the 9 reports, 2 (22.2%) required hospitalization.
Is Therapy cessation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CLOBETASOL. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does CLOBETASOL Cause?
Drug ineffective (3,217)
Psoriasis (1,317)
Product use in unapproved indication (706)
Pruritus (697)
Therapeutic product effect incomplete (643)
Skin exfoliation (550)
Off label use (540)
Treatment failure (535)
Erythema (464)
Arthralgia (417)
What Other Drugs Cause Therapy cessation?
DALFAMPRIDINE (4,580)
ETANERCEPT (2,031)
ADALIMUMAB (1,712)
ABIRATERONE (1,602)
VOXELOTOR (1,038)
CLOZAPINE (885)
LOMITAPIDE (828)
CAPECITABINE (746)
TREPROSTINIL (743)
ISOTRETINOIN (633)
Which CLOBETASOL Alternatives Have Lower Therapy cessation Risk?
CLOBETASOL vs CLOBETASONE
CLOBETASOL vs CLODRONATE
CLOBETASOL vs CLOFARABINE
CLOBETASOL vs CLOFAZIMINE
CLOBETASOL vs CLOMETHIAZOLE